BMY

On Monday, Bristol Myers Squibb & Co BMY agreed to acquire 2seventy bio, Inc. TSVT at $5.00 per share in an all-cash...

Healthcare is considered a defensive industry, since good medical care is needed regardless of economic or market conditions. Therefore many...

When the Federal Reserve met in December, it threw the stock market and Wall Street a pretty big curveball when...

Bristol Myers Squibb (BMY) concluded the recent trading session at $56.81, signifying a -0.58% move from its prior day's close.

Bristol Myers stock has performed well in the past year, gaining 11%. We believe there is more room for further...

Large-capitalization blue-chip dividend stocks are a favorite among investors for a good reason.

Bristol Myers Squibb (BMY) closed the most recent trading day at $56.59, moving -0.35% from the previous trading session.

Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be...

The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to...